Get Screened for Oral, Head and Neck Cancer June 7
CINCINNATITo raise awareness about the signs and symptoms of oral, head and neck cancer, UC health specialists are offering free screenings Thursday, June 7, at the UC Health Barrett Center.
UC Health head and neck cancer specialist Keith Casper, MD, says early awareness and diagnosis can affect the outcome for many patients with oral, head and neck cancers.
He says diagnosing these cancers early can mean more treatment options for patients, including less invasive surgeries that reduce recovery time and have fewer side effects.
The American Cancer Society lists head and neck cancers as the sixth most common form of cancer in the United States, but research shows many do not understand where these cancers are, what causes them and how they are diagnosed.
Signs and symptoms to watch out for include:
- A sore or pain in the mouth or on the tongue that doesnt resolve or is increasing in size
- Pain around the teeth or loosening of the teeth
- Difficulty chewing, swallowing or moving the tongue or jaw
- Swelling of the jaw that causes dentures to fit poorly
- Constant bad breath
- A lump or mass in the neck
Oral, head and neck cancer is more common in men than in women, and predominantly diagnosed in older adults with a history of tobacco and alcohol use.
However, says Casper, doctors have seen a recent rise in oropharyngeal cancer related to infection with human papilloma virus (HPV). Those cases have been found among typically low-risk populations, such as patients in their 50s and non-smokers or non-drinkers.
"Its easy to assume that head and neck cancer patients are all long-standing smokers, says Casper. "But HPV has changed the demographics of this disease. Were seeing cases of HPV-related oropharyngeal cancer in people who have never smoked or drank. If we can catch these cases early, the better the outcome for the patient.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.